Our tech platform
Originating from MIT, we’ve spent years clinically validating our novel platform.
About our platform
Our investigational medical device delivers non-invasive neuromodulation with the potential to improve outcomes in a range of neurodegenerative diseases, including Alzheimer’s disease, and is personalized based on your brain’s responses.
Intuitive experience for at-home patient self-administration.
How it works
Self-administered use in the comfort of patients’ homes
Personalized sensory stimulation facilitates long-term engagement
Support in the palm of your hand
Mechanism of Action
Cognito uses sensory stimulation to evoke gamma oscillations in the brain that have
been shown to improve synaptic connections between neurons, activate microglia, and enhance removal of pathological proteins
from the brain.
This leads to reduced neurodegeneration and brain atrophy, as well as improved sleep, cognitive and functional abilities.
Leveraging our platform across multiple neurodegenerative diseases
Mild Cognitive Impairment